Wnt信号通路
癌症研究
癌症
连环素
癌变
信号转导
药理学
小干扰RNA
医学
生物
内科学
细胞生物学
基因
核糖核酸
生物化学
作者
Xi Zhao,Yunong Ma,Jiayang Luo,Kexin Xu,Peilin Tian,Cuixia Lu,Jiaxing Song
出处
期刊:Heliyon
[Elsevier BV]
日期:2024-08-01
卷期号:10 (16): e35989-e35989
被引量:61
标识
DOI:10.1016/j.heliyon.2024.e35989
摘要
The WNT/β-catenin signaling pathway plays crucial roles in tumorigenesis and relapse, metastasis, drug resistance, and tumor stemness maintenance. In most tumors, the WNT/β-catenin signaling pathway is often aberrantly activated. The therapeutic usefulness of inhibition of WNT/β-catenin signaling has been reported to improve the efficiency of different cancer treatments and this inhibition of signaling has been carried out using different methods including pharmacological agents, short interfering RNA (siRNA), and antibodies. Here, we review the WNT-inhibitory effects of some FDA-approved drugs and natural products in cancer treatment and focus on recent progress of the WNT signaling inhibitors in improving the efficiency of chemotherapy, immunotherapy, gene therapy, and physical therapy. We also classified these FDA-approved drugs and natural products according to their structure and physicochemical properties, and introduced briefly their potential mechanisms of inhibiting the WNT signaling pathway. The review provides a comprehensive understanding of inhibitors of WNT/β-catenin pathway in various cancer therapeutics. This will benefit novel WNT inhibitor development and optimal clinical use of WNT signaling-related drugs in synergistic cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI